Primary Record
Meproscillarin
- In stock
- 8,598 g
- Purity
- 98.3 %
- CAS
- 33396-37-1
Compound Identifiers & Properties
- CAS
- 33396-37-1
- PubChem CID
- 15942714
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)OC
- Canonical SMILES
- CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)O[C@H]1C
Names & Synonyms
- Meproscillarin
- Meproscillarine
- Meproscilarina
- Rambufaside
- Clift
- Meproscillarinum
- Meprosillarin
- Ranbufaside
- methylproscillaridin
- methyl proscillaridin
- Knoll 570
- Meproscilarina [Spanish]
- Proscillaridin-4-methyl ether
- Methyl proscillaridin A
- 4-O-Methyl-proscillaridin
- Meproscillarin [INN:BAN]
- RefChem:905982
- UNII-WYR1723LO7
- WYR1723LO7
- Meproscilarina [INN-Spanish]
- Meproscillarine [INN-French]
- Meproscillarinum [INN-Latin]
- Ky 18
- Meproscillarin [BAN:INN]
- Proscillaridin-4'-methyl ether
- KY-18
- MEPROSCILLARIN [INN]
- SCHEMBL36006
- Proscillaridin 4-methyl ether
- 33396-37-1
- MEPROSCILLARIN [MART.]
- proscillaridin 4'-methyl ether
- DTXSID101031613
- orb1696152
- MEPROSCILLARIN [WHO-DD]
- CHEMBL2106427
- EINECS 251-493-6
- CHEBI:135824
- Proscillaridin 4 -methyl ether
- RKWPZPDLTYBKCL-RVZGXXANSA-N
- DTXCID001516632
- C31H44O8
- ZINC8214606
- AKOS040753000
- C31-H44-O8
- 2-(3-bromobut-3-enyl)-1,3-dioxolane
- J17.706G
- HY-106565
- PROSCILLARIDIN-4-METHYL ETHER [MI]
- CS-0026063
- Methyl proscillaridin; Methyl proscillaridin A
- Q27293057
- 5-[(3S,8R,9S,10R,13R,14S,17R)-3-[(2R,3R,4S,5R,6S)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
- 14-Hydroxy-3-beta-((4-O-methyl-alpha-L-rhamnopyranosyl)oxy)-14-beta-bufa-4,20,22-trienlid
- 3beta-((6-Deoxy-4-O-methyl-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide
- 2-((6-amino-4-(4-chlorophenyl)-3,5-dicyanopyridin-2-yl)thio)acetamide
- 2-amino-6-(2-hydroxyethylsulfanyl)-4-phenylpyridine-3,5-dicarbonitrile
- 3beta-[(4-O-Methyl-6-deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide
- 3beta-[(6-Deoxy-4-O-methyl-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide
- benzyl 2-((6-amino-3,5-dicyano-4-(4-methoxyphenyl)pyridin-2-yl)thio)acetate
- (3beta)-3-((6-Deoxy-4-O-methyl-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide
- 14-beta-Bufa-4,20,22-trienolide, 3-beta-((6-deoxy-4-O-methyl-alpha-L-mannopyranosyl)oxy)-14-hydroxy-
- 251-493-6
- 3.BETA.-((6-DEOXY-4-O-METHYL-.ALPHA.-L-MANNOPYRANOSYL)OXY)-14-HYDROXYBUFA-4,20,22-TRIENOLIDE
- 333960-08-0
- 333960-26-2
- 333960-78-4
- 333961-98-1
- 5-((3S,8R,9S,10R,13R,14S,17R)-3-(((2R,3R,4S,5R,6S)-3,4-dihydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-hydroxy-10,13-dimethyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-pyran-2-one
- 5-[(1R,3aS,3bR,7S,9aR,9bS,11aR)-7-{[(2R,3R,4S,5R,6S)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2H-pyran-2-one
- 5-[(3S,8R,9S,10R,13R,14S,17R)-3-[(2S,5R)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
- Bufa-4,20,22-trienolide, 3-((6-deoxy-4-O-methyl-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-
- Bufa-4,20,22-trienolide, 3-[(6-deoxy-4-O-methyl-.alpha.-L-mannopyranosyl)oxy]-14-hydroxy-, (3.beta.)-